Abstract
The purpose of this study is to explain the rationale for the value of information approach to priority setting for research and to describe the methods intuitively for those familiar with basic decision analytical modeling. A policy-relevant case study is used to show the feasibility of the method and to illustrate the type of output that is generated and how these might be used to frame research recommendations. The case study relates to the use of glycoprotein IIb/IIIa antagonists for the treatment of patients with non-ST elevation acute coronary syndrome. This is an area that recently has been appraised by the National Institute for Health and Clinical Excellence.
| Original language | English |
|---|---|
| Pages (from-to) | 379-387 |
| Number of pages | 8 |
| Journal | International Journal of Technology Assessment in Health Care |
| Volume | 22 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jul 2006 |
Bibliographical note
Copyright © 2006 Cambridge University Press. Uploaded in accordance with the publisher's self-archiving policy.Keywords
- priority setting
- value of information
- glycoprotein IIb/IIIa antagonists
- COST-EFFECTIVENESS ANALYSIS
- MYOCARDIAL-INFARCTION
- DECISION-MAKING
- EXPECTED VALUE
- INVESTMENTS
- TECHNOLOGY
- STRATEGIES
- MANAGEMENT
- DISEASE
- RULES